The COMPASS project (Cardio-Oncology Multidisciplinary Patient ASsistance Solution) has been launched to develop innovative solutions that strengthen cardio-oncology services. The five-year initiative is funded by the European Union under the Innovative Health Initiative (IHI) and brings together more than 60 partners from 25 countries including hospitals, research centres, universities, MedTech companies, SMEs, and patient organisations.
Oxford University Hospitals (OUH) NHS Foundation Trust is one of the project partners and will receive €399,000 in funding. Daniel McGowan, Associate Professor in the Department of Oncology and Head of Education and Research in the Department of Medical Physics and Clinical Engineering at OUH, will lead the Oxford team in collaboration with GE HealthCare. Their research is focus on how they can adapt routine PET scans to also assess a patient’s heart health.
Zoe Wilson, a Research Scientist at OUH and DPhil student in the Department of Oncology is also part of the COMPASS project, investigating how PET scan data can be repurposed to assess heart health. As part of this project, she will use data from hospitals in Belgium, the Netherlands and Portugal. This expanded dataset opens up opportunities to use AI and machine learning to analyse the scan and improve the early identification of patients at risk of heart problems.
Read the full story on the Department of Oncology website.